Blake Hildreth

Dr. Blake Hildreth

orcid

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 May 2015 in Veterinary Pathology
Verified
Journal Article
Open access
PDF file
JSJ. K. Simmons
J. K. Simmons
BHBlake Hildreth
Blake Hildreth
WSW. Supsavhad
W. Supsavhad
SES. M. Elshafae
S. M. Elshafae
BHBardes Hassan
Bardes Hassan
TRThomas Rosol
Thomas Rosol
Bone is one of the most common sites of cancer metastasis in humans and is a significant source of morbidity and mortality. Bone metastases are considered incurable and result in pain, pathologic fracture, and decreased quality of life. Animal models of skeletal metastases are essential to improve the understanding of the molecular pathways of cancer metastasis and growth in bone and to develop new therapies to inhibit and prevent bone metastases. The ideal animal model should be clinically relevant, reproducible, and representative of human disease. Currently, an ideal model does not exist; however, understanding the strengths and weaknesses of the available models will lead to proper study design and successful cancer research. This review provides an overview of the current in vivo animal models used in the study of skeletal metastases or local tumor invasion into bone and focuses on mammary and prostate cancer, lymphoma, multiple myeloma, head and neck squamous cell carcinoma, and miscellaneous tumors that metastasize to bone.

3 December 2008 in Veterinary Surgery
Verified
Journal Article
Closed access
PDF file
APAntonio Pozzi
Antonio Pozzi
BHBlake Hildreth
Blake Hildreth
PRPaivi J. Rajala‐Schultz
Paivi J. Rajala‐Schultz

9 February 2010 in The FASEB Journal
Verified
Journal Article
Open access
PDF file
RTRamiro Toribio
Ramiro Toribio
HBHolly A. Brown
Holly A. Brown
CNChad M. Novince
Chad M. Novince
BMBrandlyn Marlow
Brandlyn Marlow
KHKrista Hernon
Krista Hernon
TRThomas Rosol
Thomas Rosol
The functions of parathyroid hormone‐related protein (PTHrP) on morphogenesis, cell proliferation, apoptosis, and calcium homeostasis have been attributed to its N terminus. Evidence suggests that many of these effects are not mediated by the N terminus but by the midregion, a nuclear localization sequence (NLS), and C terminus of the protein. A knock‐in mouse lacking the midregion, NLS, and C terminus of PTHrP ( Pthrp △/△ ) was developed. Pthrp △/△ mice had craniofacial dysplasia, chondrodysplasia, and kyphosis, with most mice dying by d 5 of age. In bone, there were fewer chondrocytes and osteoblasts per area, bone mass was decreased, and the marrow was less cellular, with erythroid hypoplasia. Cellular proliferation was impaired, and apoptosis was increased. Runx2, Ocn, Sox9, Crtl1 , ß ‐catenin, Runx1, ephrin B2, cyclin D1 , and Gata1 were underexpressed while P16/ Ink4a, P21, GSK‐3 ß, Il‐6, Ffg3 , and Ihh were overexpressed. Mammary gland development was aberrant, and energy metabolism was deregulated. These results establish that the midregion, NLS, and C terminus of PTHrP are crucial for the commitment of osteogenic and hematopoietic precursors to their lineages, and for survival, and many of the effects of PTHrP on development are not mediated by its N terminus. The down‐regulation of Runx1, Runx2 , and Sox9 indicates that PTHrP is a modulator of transcriptional activation during stem cell commitment. Toribio, R E., Brown, H. A., Novince, C. M., Marlow, B. Hernon, K., Lanigan, L. G., Hildreth III, B. E., Werbeck, J. L., Shu, S. T., Lorch, G., Carlton, M., Foley, J., Boyaka, P., McCauley, L. K., Rosol, T. J. The midregion, nuclear localization sequence, and C terminus of PTHrP regulate skeletal development, hematopoiesis, and survival in mice. FASEB J . 24, 1947–1957 (2010). www.fasebj.org

23 April 2020 in Cancer Research
Verified
Journal Article
Open access
PDF file
KTKatie A. Thies
Katie A. Thies
AHAnisha M. Hammer
Anisha M. Hammer
BHBlake Hildreth
Blake Hildreth
SSSarah A. Steck
Sarah A. Steck
JSJonathan M. Spehar
Jonathan M. Spehar
GSGina Sizemore
Gina Sizemore
Platelet-derived growth factor receptor-beta (PDGFRβ) is a receptor tyrosine kinase found in cells of mesenchymal origin such as fibroblasts and pericytes. Activation of this receptor is dependent on paracrine ligand induction, and its preferred ligand PDGFB is released by neighboring epithelial and endothelial cells. While expression of both PDGFRβ and PDGFB has been noted in patient breast tumors for decades, how PDGFB-to-PDGFRβ tumor–stroma signaling mediates breast cancer initiation, progression, and metastasis remains unclear. Here we demonstrate this paracrine signaling pathway that mediates both primary tumor growth and metastasis, specifically, metastasis to the brain. Elevated levels of PDGFB accelerated orthotopic tumor growth and intracranial growth of mammary tumor cells, while mesenchymal-specific expression of an activating mutant PDGFRβ (PDGFRβD849V) exerted proproliferative signals on adjacent mammary tumor cells. Stromal expression of PDGFRβD849V also promoted brain metastases of mammary tumor cells expressing high PDGFB when injected intravenously. In the brain, expression of PDGFRβD849V was observed within a subset of astrocytes, and aged mice expressing PDGFRβD849V exhibited reactive gliosis. Importantly, the PDGFR-specific inhibitor crenolanib significantly reduced intracranial growth of mammary tumor cells. In a tissue microarray comprised of 363 primary human breast tumors, high PDGFB protein expression was prognostic for brain metastases, but not metastases to other sites. Our results advocate the use of mice expressing PDGFRβD849V in their stromal cells as a preclinical model of breast cancer–associated brain metastases and support continued investigation into the clinical prognostic and therapeutic use of PDGFB-to-PDGFRβ signaling in women with breast cancer. Significance: These studies reveal a previously unknown role for PDGFB-to-PDGFRβ paracrine signaling in the promotion of breast cancer brain metastases and support the prognostic and therapeutic clinical utility of this pathway for patients. See related article by Wyss and colleagues, p. 594

28 March 2018 in Bone Research
Verified
Journal Article
Open access
PDF file
HCHeather A. Carey
Heather A. Carey
BHBlake Hildreth
Blake Hildreth
JGJennifer A. Geisler
Jennifer A. Geisler
MNMara C. Nickel
Mara C. Nickel
JCJennifer Cabrera
Jennifer Cabrera
SSSudarshana M. Sharma
Sudarshana M. Sharma
Genome-wide association studies (GWASs) have been instrumental in understanding complex phenotypic traits. However, they have rarely been used to understand lineage-specific pathways and functions that contribute to the trait. In this study, by integrating lineage-specific enhancers from mesenchymal and myeloid compartments with bone mineral density loci, we were able to segregate osteoblast- and osteoclast (OC)-specific functions. Specifically, in OCs, a PU.1-dependent transcription factor (TF) network was revealed. Deletion of PU.1 in OCs in mice resulted in severe osteopetrosis. Functional genomic analysis indicated PU.1 and MITF orchestrated a TF network essential for OC differentiation. Several of these TFs were regulated by cooperative binding of PU.1 with BRD4 to form superenhancers. Further, PU.1 is essential for conformational changes in the superenhancer region of Nfatc1. In summary, our study demonstrates that combining GWASs with genome-wide binding studies and model organisms could decipher lineage-specific pathways contributing to complex disease states.

5 November 2014 in Synthetic Metals
Verified
Journal Article
Closed access
YMYonggang Min
Yonggang Min
YLYidong Liu
Yidong Liu
YPYadagiri Poojari
Yadagiri Poojari
JWJen-Chieh Wu
Jen-Chieh Wu
BHBlake Hildreth
Blake Hildreth
AEArthur J. Epstein
Arthur J. Epstein